GlassScriptPhysician profile
Avinash Mohinder Sud
NPI 1891748653
$2,227.71
in general payments reported to CMS, 2019-2025
11 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,860 · 2020: $97.62 · 2021: $87.84 · 2022: $65.03 · 2023: $16.47 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,660.83 | 2019 | |
| Depuy Synthes Sales INC. | $165.68 | 2019-2022 | |
| Penumbra, INC. | $101.13 | 2025 | Ruby Coil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.62 | 2020 | |
| Terumo Medical Corporation | $87.50 | 2019 | |
| Medtronic, INC. | $44.31 | 2021-2022 | |
| Angiodynamics, INC. | $24.36 | 2021 | |
| Teleflex LLC | $16.47 | 2023 | Arrow |
| Medtronic USA, INC. | $14.04 | 2019 | |
| Stryker Corporation | $11.14 | 2019 | |
| Merit Medical Systems INC | $4.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinash Sud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.